Rheumatoid Arthritis Flashcards
Prevalence of RA
0.5-1%
Age and gender of RA
30-60 years, female
What is the reduced life expectancy of RA?
7-10 years
Which environmental factors lead to the progression of RA?
smoking, periodontitis, gut microbiome
What is the shared epitope of RA?
The amino acid motif QKRAA in the HLA-DRB1 region
Which bacteria in periodontal disease is an environmental factor in RA?
prophyromonas gingivalis
When do anti CCP antibodies peak?
disease onset to first year of symptoms
What are the autoantibodies in RA?
RF, ACPA, anti-PAD4, AntiCarP, Anti-MDA, Anti-MMA
What are RF antibodies directed against?
Fc portion of human IgG
What percentage of patients with RA will have positive RF?
75%
Who has more severe disease seropositive or seronegaitve patients?
seropositive
Which other autoimmune diseases may have positive RF?
sjogrens, cryoglobulinaemia, SLE
Which non autoimmune diseases may have positive RF?
chronic infection (hep B, hep C), cancer
What is citrullination?
the post translational conversion of peptidylarginine to peptidylcitrulline
What are ACPAs associated with?
more severe disease, RA related lung disease, cardiovascular disease
What are the key cytokines in RA?
TNF, IL-17A, IL-17F, IL-1alpha, IL-1beta, IL-6
Which joints are spared in RA?
DIP
What is RS3PE syndrome?
Remitting, seronegative, symmetric synovitis with pitting edema syndrome:
- oedema of dorsum of hand or foot
- tenosynovitis
- seronegative for RF and ACPA
- responds well to glucocorticoids
- can be paraneoplastic
Which direction does the wrist deviate?
radial
Which direction do the fingers deviate at the MCP?
ulnar
What are the dermatologic manifestations of RA?
rheumatoid nodules, vasculitis, ulcers, neutrophilic dermatoses, treatment related rashes
What are the opthalmologic manifestations of RA?
episcleritis, scleritis, perilimbic ischaemic ulcers, secondary sjogren’s syndrome
What are the pulmonary manifestations of RA?
pleural effusions, nodules, cricoaretynoid arthritis, interstitial lung disease, bronchiectasis, cryptogenic organising pneumonia
What are the cardiovascular manifestations of RA?
premature atherosclerosis, pericarditis, pericardial effusion, arrhythmias, myocarditis, heart failure, cardiac nodules
What are the GI manifestations of RA?
xerostomia, gastritis (from NSAIDs), stomatitis, mucositis (from methotrexate)
What are the renal manifestations of RA?
glomerulonephritis, proteinuria, treatment related kidney injury
What are the hepatic manifestations of RA?
nodular regenerative hyperplasia, portal fibrosis, treatment related hepatitis/cirrhosis
What are the haematological manifestations of RA?
lymphadenopathy, felty syndrome, lymphoma, amyloidosis, cryoglobulinaemia, large granular lymphocyte syndrome
What are the radiographic characteristics of RA?
Periarticular soft tissue swelling (joint effusion, tenosynovitis) Juxta-articular osteoporosis Marginal erosions Joint space narrowing Symmetric involvement Deformities in advanced disease
Which is the most important DMARD?
methotrexate
What is the dose of methotrexate?
15-25mg weekly
What are the adverse effects of methotrexate?
nausea, hair loss, stomatitis, hepatotoxicity, cytopaenias, pneumonitis, teratogenecity
What is the efficacy (ACR70 response rate) of methotrexate?
20-40%
How is methotrexate excreted?
renally
What is the dose of sulfasalazine?
2-4g daily
What is the efficacy (ACR70 response rate) of sulfasalazine?
8% at 2g/d
What are the adverse effects of sulfasalazine?
hypersensitivity reactions, nausea, diarrhoea, agranulocytosis, drug induced lupus, azoospermia
What are the adverse effects of hydroxychloroquine?
hyperpigmentation, retinopathy, myopathy, cardiomyopathy
What is the mechanism of action of leflunomide?
inhibition of DHODH (dihydrooratedehydrogenase), an enzyme in de novo pyrimidine synthesis (required for T-cell activation)
What is the dose of leflunomide?
10-20mg daily
What are the adverse effects of leflunomide?
Diarrhoea(~25%) Hypertension Hypersensitivity reactions LFTs and pneumonitis (esp. if combined with methotrexate and b/g ILD) Leukocytopenia Teratogenicity Peripheral neuropathy
What are the different types of biologic DMARDs?
TNF inhibitors, Anti-CD20, IL-6R inhibitor, Jak inhibitors, T cell costimulation inhibitors
What are the contraindications for TNF inhibitors?
SLE Demyelinating disorders Current, active, serious infection Recurrent or chronic infection Untreated latent or active mycobacterial infection Hepatitis B infection Congestive heart failure Pregnancy
What are the adverse effects of TNF inhibitors?
Infections (including serious infections) Opportunistic infections (e.g., tuberculosis) Malignancies (skin cancer, lymphoma [?]) Demyelinating conditions Autoantibodies (ANA, anti–ds DNA) Hepatotoxicity Dermatologic reactions Lupus-like syndromes
What is abatacept?
A T-cell costimulation inhibitor
What is tocilizumab?
An IL-6 receptor inhibitor
Why can’t CRP be used as a measure of infection in patients on tocilizumab?
Because IL-6 is a driver of inflammation so CRP may be normal
What are the adverse effects of tocilizumab?
Infections Deranged LFTs Thrombocytopaenia Neutropaenia GI perforation Anaphylaxis
What is rituximab?
An anti CD-20 antibody that depletes B cells but spares plasma cells
What are the adverse effects of rituximab?
Infections, infusion reactions, diminished response to vaccination, reactivation of hepatitis B, rarely: progressive multifocal leukoencephalopathy
What are the adverse effects of jak inhibitors?
infections
herpes zoster
cytopaenias
hyperlipidaemia
What is the standard strategy for RA treatment?
first line: start methotrexate plus short term glucocorticoids
second line: add a biologic DMARD or targeted synthetic DMARD
third line: use a different biologic or targeted synthetic
when in remission phase taper doses or increase time between treatment
How should you manage cardiovascular risk in patients with RA?
measure lipids while in remission or low disease activity